Oliver Hodgkiss is an associate in the firm’s global life sciences transactions team. He advises multinational and emerging companies in the life sciences sector on transactions at all stages of the product life-cycle. Oliver’s practice focuses on strategic collaborations, licensing, supply and manufacturing arrangements, and other commercial and IP matters relating to drug development and commercialisation. Oliver also regularly advises clients on commercial and IP due diligence in connection with their strategic M&A transactions.